Learning health care systems: Highly needed but challenging

Learning Health Systems
Roel H P WoutersAnnelien L Bredenoord

Abstract

Learning health care systems (LHSs) have the potential to transform health care. However, this transformation process faces significant challenges. Based on proposals and early examples of LHSs in the literature and conceptual analysis of the LHS mission, we provide four models with distinct organizational and ethical implications that may facilitate the transformation. An LHS could be developed in the following ways: by taking away practical impediments that prevent patients and professionals from engaging in scientific research (model 1: optimization LHS); by routinely analyzing observational data from electronic health records and other sources (model 2: comprehensive data LHS); by making clinical decisions based on the outcomes of the aforementioned data analyses and directly evaluating the outcomes in order to continuously improve decision-making (model 3: real-time LHS); or by embedding clinical trials into routine care delivery (model 4: full LHS). Each model has different ethical implications for consent and oversight. Also, the four-model approach shows that reorganizing a health care center into an LHS is not an all-or-nothing decision. Rather, it is a choice from a menu of possibilities. Instead of discussing the adv...Continue Reading

References

Jun 30, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Amy P AbernethySharon B Murphy
May 30, 2013·American Society of Clinical Oncology Educational Book·George W SledgeRobert Hauser
Sep 3, 2013·The New England Journal of Medicine·Michael S Lauer, Ralph B D'Agostino
Jan 22, 2014·Nature Reviews. Clinical Oncology·Jeff Shrager, Jay M Tenenbaum
Feb 21, 2014·The New England Journal of Medicine·Ruth R FadenNancy E Kass
Mar 13, 2014·Journal of Patient Safety·Danielle M WhicherAbha Saxena
Apr 23, 2014·Nature Reviews. Clinical Oncology·Hashim U AhmedUNKNOWN Prostate Cancer RCT Consensus Group
Jun 5, 2014·The New England Journal of Medicine·Sebastian Schneeweiss
Jul 10, 2014·Health Affairs·Christopher A LonghurstNigam H Shah
Sep 17, 2015·Clinical Trials : Journal of the Society for Clinical Trials·Jonathan A FinkelsteinJeremy Sugarman
Oct 16, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jan R R LewisWendy Lipworth
Jan 18, 2016·Advanced Drug Delivery Reviews·Philippe LambinSean Walsh
Jan 19, 2016·Kennedy Institute of Ethics Journal·Franklin G Miller, Scott Y Kim
May 18, 2016·Theoretical Medicine and Bioethics·David Wendler, Rebecca Johnson
Jul 3, 2016·BMJ : British Medical Journal·Eugene C NelsonStaffan Lindblad
Sep 17, 2016·Science·Jeff Shrager
Oct 4, 2016·Journal of Biomedical Informatics·Andrius Budrionis, Johan Gustav Bellika
Oct 11, 2016·Healthcare : the Journal of Delivery Science and Innovation·William H GruberJohn B Torous
Mar 4, 2017·Circulation·Thomas M MaddoxUNKNOWN American Heart Association Council on Quality of Care and Outcomes Research; Council on Cardiovascular Disease in the Young;
Mar 31, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kala VisvanathanGary H Lyman
Dec 2, 2017·Science·Rebecca Eisenberg, Harold Varmus
Dec 12, 2017·Clinical Trials : Journal of the Society for Clinical Trials·Scott Yh KimClare Relton
Jan 27, 2018·BMJ : British Medical Journal·Spencer Phillips HeyAaron S Kesselheim
Feb 3, 2018·International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care·Stuart McLennanHolger Langhof
Mar 29, 2018·Journal of Public Health·Frédéric B PielPaul Elliott
Apr 25, 2018·BMJ : British Medical Journal·Clare TurnbullUNKNOWN 100 000 Genomes Project
Nov 7, 2018·Journal of Innovation in Health Informatics·Scott McLachlanNorman Fenton
Feb 8, 2019·JCO Clinical Cancer Informatics·Seán WalshPhilippe Lambin
May 1, 2019·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S B van Waalwijk van Doorn-KhosrovaniE E Voest
Jan 29, 2020·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S B van Waalwijk van Doorn-KhosrovaniE E Voest

❮ Previous
Next ❯

Citations

Dec 30, 2020·The American Journal of Bioethics : AJOB·Rieke van der GraafMartine C de Vries
Jul 3, 2021·Journal of Personalized Medicine·Roel H P WoutersAnnelien L Bredenoord

❮ Previous
Next ❯

Software Mentioned

EUROCAT
CancerLinQ

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

BMJ Health & Care Informatics
Scott McLachlanHiKER (Health informatics and Knowledge Engineering Research) Group
Journal of Comparative Effectiveness Research
C Daniel MullinsAnthony Wutoh
Seminars in Pediatric Surgery
Katherine J DeansChristopher B Forrest
Journal of Innovation in Health Informatics
Scott McLachlanNorman Fenton
© 2021 Meta ULC. All rights reserved